Pasithea Therapeutics Corp (KTTA)

CUSIP: 70261F202 | NYSE | Healthcare · Biotechnology | Micro Cap | 44 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13G/AVivo Opportunity Fund Holdings, L.P. with Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P.	9,286,738	10.0%	New 5%+ stake	Jun 30, 2026	No 13F filer matched
13G/AOpaleye Management Inc.

Institutional Holders — Q3 2026

Sort by

SBI Securities Co., Ltd.1,051

0.0% of portfolio$518

				Style	Turnover	Location	Filed
SBI Securities Co., Ltd.	1,051	$518	0.0%	Agg Growth	Low	Tokyo, Mexico	2026-10-22

13G/AVivo Opportunity Fund Holdings, L.P.9,286,738

10.0% of class · Jun 30, 2026New 5%+ stake

with Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P.

No 13F filer matched

13G/AOpaleye Management Inc.2,050,000

6.1% of class · Jun 30, 2026New 5%+ stake

No 13F filer matched

13G/ACoastlands Capital GP LLC3,835,035

11.5% of class · Apr 9, 2026New 5%+ stake

No 13F filer matched